Cargando…
Glaucoma : an open window to neurodegeneration and neuroprotection /
An in-depth examination on risk factors, diagnosis, clinical monitoring and treatment of glaucoma.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; London :
Elsevier,
2008.
|
| Edición: | 1. edition. |
| Colección: | Progress in brain research ;
v. 173. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo Texto completo Texto completo |
Tabla de Contenidos:
- 1. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
- 2. Predictive models to estimate the risk of glaucoma development and progression
- 3. Intraocular pressure and central corneal thickness
- 4. Angle-closure: risk factors, diagnosis and treatment
- 5. Early diagnosis of glaucoma
- 6. Monitoring glaucoma progression
- 7. Standard automated perimetry and algorithms for monitoring glaucoma progression
- 8. Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma
- 9. Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma
- 10. The role of OCT in glaucoma management
- 11. Functional laser Doppler flowmetry of the optic nerve: physiological aspects and clinical applications
- 12. Advances in neuroimaging of the visual pathways and their use in glaucoma
- 13. Primary open angle glaucoma: an overview of medical therapy
- 14. The treatment of normal-tension glaucoma
- 15. The management of exfoliative glaucoma
- 16. Laser therapies for glaucoma: new frontiers
- 17. Modulation of wound healing during and after glaucoma surgery
- 18. Surgical alternative to trabeculectomy
- 19 Modern aqueous shunt implantation: future challenges
- 20. Model systems for experimental studies: retinal ganglion cells in culture
- 21. Rat models for glaucoma research
- 22. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection
- 23. Clinical trials in neuroprotection.
- 24. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria
- 25. Astrocytes in glaucomatous optic neuropathy
- 26. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation
- 27. Oxidative stress and glaucoma: injury in the anterior segment of the eye
- 28 TNF-alpha signaling in glaucomatous neurodegeneration
- 29. Involvement of the Bc12 gene family in the signaling and control of retinal ganglion cell death
- 30. Assessment of neuroprotection in the retina with DARC
- 31. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
- 32. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
- 33. Changes of central visual receptive fields on experimental glaucoma
- 34. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
- Stem cells for neuroprotection in glaucoma
- 36. The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells
- 37. Evidence of the neuroprotective role of citicoline in glaucoma patients
- 38. Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon
- 39. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection
- 40. 17Beta-estradiol prevents retinal ganglion cell loss induced by the acute rise of intraocular pressure in rat.